DJIA 17,416.85 225.48 1.31%
NASDAQ 4,683.41 45.41 0.98%
S&P 500 2,021.25 19.09 0.95%
market minute promo

Novartis (NYSE: NVS)



company name or ticker
Company Photos
(Click to zoom)

Incyte's Phase III RESPONSE Data on Jakafi Published - Analyst Blog

Roche Misses on Earnings in 2014, Beats on Revenues - Analyst Blog

Pharma News: Synthetic Biology Finds Path to Clinic Through Novartis

Hey Obama, how's this for precision medicine? Novartis will combine CAR-T and CRISPR/Cas9 technologies. Stem cells could get a boost, too.

Novartis (NVS) Up on Earnings and Revenue Beat in Q4 - Analyst Blog

Amgen Beats on Q4 Earnings & Revenues, Maintains Outlook - Analyst Blog

Amgen Beats on Q4 Earnings & Revenues, Maintains Outlook - Analyst Blog

Update: Novartis - Solid FY15 Guidance, All Eyes On The Upcoming Launches

Novartis AG (NVS) Earnings Report: Q4 2014 Conference Call Transcript

Novartis (NVS) Stock Gains Today on Earnings Beat

Novartis' (NVS) CEO Joe Jimenez on Q4 2014 Results - Earnings Call Transcript

Does This 50% Price Target Hike For Array BioPharma Inc. Make Sense?

Stifel Nicolaus boosted its price target on cancer drug developer Array BioPharma by a substantial amount on Monday. Is this price hike warranted or is it full of fluff?
See More Articles...